- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有220家主力机构披露2025-06-30报告期持股数据，持仓量总计5.20亿股，占流通A股55.26%
- 波段诊断：
-
技术面诊股
诊断结果：6.1技术面打败了58%的股票
技术面评分前10的股票
近期的平均成本为14.04元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为14.04元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"14.04","date":1767685883,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，明显跑赢行业平均水平。
[{"date":"2026.01.07","stock":"-0.14","trade":"1.05","ind":"0.06"},{"date":"2026.01.06","stock":"0.57","trade":"0.42","ind":"1.40"},{"date":"2026.01.05","stock":"1.83","trade":"3.31","ind":"2.24"},{"date":"2025.12.31","stock":"-0.65","trade":"-0.13","ind":"-0.58"},{"date":"2025.12.30","stock":"-0.86","trade":"-0.53","ind":"0.49"},{"date":"2025.12.29","stock":"-1.70","trade":"-1.04","ind":"-0.49"},{"date":"2025.12.26","stock":"1.58","trade":"-0.26","ind":"0.54"},{"date":"2025.12.25","stock":"-0.64","trade":"0.22","ind":"0.33"},{"date":"2025.12.24","stock":"6.86","trade":"0.78","ind":"0.88"},{"date":"2025.12.23","stock":"-2.67","trade":"-0.53","ind":"0.27"},{"date":"2025.12.22","stock":"0.60","trade":"-0.21","ind":"1.47"},{"date":"2025.12.19","stock":"0.30","trade":"1.09","ind":"0.66"},{"date":"2025.12.18","stock":"-1.11","trade":"-0.16","ind":"-1.29"},{"date":"2025.12.17","stock":"1.05","trade":"0.83","ind":"2.40"},{"date":"2025.12.16","stock":"-0.15","trade":"-1.60","ind":"-1.51"},{"date":"2025.12.15","stock":"-0.96","trade":"-1.38","ind":"-1.10"},{"date":"2025.12.12","stock":"-1.10","trade":"0.13","ind":"0.84"},{"date":"2025.12.11","stock":"-1.80","trade":"-0.99","ind":"-1.27"},{"date":"2025.12.10","stock":"-0.14","trade":"0.09","ind":"0.29"},{"date":"2025.12.09","stock":"-3.40","trade":"-1.60","ind":"-0.39"},{"date":"2025.12.08","stock":"-1.77","trade":"-0.11","ind":"1.39"}]
派林生物,深证成指,生物制品指数
压力支撑
该股压力位为14.04元，支撑位为13.94元。
[{"text":"\u538b\u529b\u4f4d","value":"14.04","date":1767715200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"13.94","date":1767715200,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.1资金面打败了60%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。
更新时间：01月07日 20:30
| 机构今日流向(万元) | 324.07 | 机构5日流向(万元) | 3579.02 |
| 机构10日流向(万元) | 916.07 | 机构20日流向(万元) | -5811.23 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加12462.90万股，其中基金净增仓34家，主力净减仓49家，请投资者中长期谨慎为宜。
截止2025-06-30，共220家主力机构（基金212家，一般法人7家，社保基金1家），持仓量总计51984.18万股，占流通A股55.26%
其中，基金持仓与2024-12-31相比：
增仓：73家 ，增持 1136.50万股
减仓：39家 ，减持 2460.64万股
新出现在主力名单中：95家 ，持有5723.62万股
从主力名单中消失：144家 ，原持有4275.21万股
其中，基金持仓与2024-12-31相比：
增仓：73家 ，增持 1136.50万股
减仓：39家 ，减持 2460.64万股
新出现在主力名单中：95家 ，持有5723.62万股
从主力名单中消失：144家 ，原持有4275.21万股
消息面诊股
诊断结果：5.5消息面打败了4%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 派林生物：1月6日获融资买入1237.22万元
2026-01-07 - 派林生物获13家机构调研：广东双林共有19个浆站，
2026-01-05 - 派林生物：采浆产能持续扩增 重点推动人凝血因子IX
2026-01-05 - 1月4日6家公司获基金调研
2026-01-05 - 派林生物：12月30日获融资买入918.63万元
2025-12-31 - 创新药爆发，疫苗内卷，并购活跃，医药资本市场重塑版
2025-12-30 - 派林生物：12月29日获融资买入2237.75万元
2025-12-30 - 交易进入审查关键期！“山西血液制品龙头企业”晋升“
2025-12-29 - 47亿！国药系将+1
2025-12-29 - 派林生物控股股东签署股份转让补充协议 延长最终截止
2025-12-29
消息列表
| 一般消息 | 高管变动 | 取消监事会 | 2025-12-22 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-12-05 |
| 一般消息 | 资产重组 | 公司股权转让 | 2025-09-10 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-22 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-05-12 |
| 利好 | 分红转增 | 10转3股派3.5元(含税) | 2025-04-24 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：6.1行业面打败了70%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2026.01.07","price":"0.06","value":"-0.53"},{"date":"2026.01.06","price":"1.40","value":"-1.04"},{"date":"2026.01.05","price":"2.24","value":"-0.26"},{"date":"2025.12.31","price":"-0.58","value":"0.22"},{"date":"2025.12.30","price":"0.49","value":"0.78"},{"date":"2025.12.29","price":"-0.49","value":"-0.53"},{"date":"2025.12.26","price":"0.54","value":"-0.21"},{"date":"2025.12.25","price":"0.33","value":"1.09"},{"date":"2025.12.24","price":"0.88","value":"-0.16"},{"date":"2025.12.23","price":"0.27","value":"0.83"},{"date":"2025.12.22","price":"1.47","value":"-1.60"},{"date":"2025.12.19","price":"0.66","value":"-1.38"},{"date":"2025.12.18","price":"-1.29","value":"0.13"},{"date":"2025.12.17","price":"2.40","value":"-0.99"},{"date":"2025.12.16","price":"-1.51","value":"0.09"},{"date":"2025.12.15","price":"-1.10","value":"-1.60"},{"date":"2025.12.12","price":"0.84","value":"-0.11"},{"date":"2025.12.11","price":"-1.27","value":"0.56"},{"date":"2025.12.10","price":"0.29","value":"-0.56"},{"date":"2025.12.09","price":"-0.39","value":"-0.02"},{"date":"2025.12.08","price":"1.39","value":"-1.62"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | *ST四环 | 109.48% | -0.41% | 5.3分 |
| 2 | 艾迪药业 | 26.59% | 7.43% | 6.5分 |
| 3 | 康弘药业 | 8.80% | 9.72% | 5.5分 |
| 4 | 甘李药业 | 8.60% | 1.14% | 6.2分 |
| 5 | 东宝生物 | 7.85% | 8.61% | 6.0分 |
| 6 | 西藏药业 | 5.97% | 4.94% | 5.9分 |
| 8 | 辽宁成大 | 4.34% | 6.42% | 6.2分 |
| 10 | 安科生物 | 2.98% | 2.66% | 5.7分 |
| 12 | 义翘神州 | 2.41% | 4.20% | 5.4分 |
| 14 | 特宝生物 | 1.28% | 0.19% | 5.0分 |
| 16 | 华兰生物 | 0.13% | 1.04% | 5.6分 |
| 18 | 智翔金泰 | -0.26% | 3.73% | 5.4分 |
| 20 | 优宁维 | -0.87% | 3.46% | 5.4分 |
| 22 | 近岸蛋白 | -1.21% | -4.00% | 4.5分 |
| 24 | 康泰生物 | -1.60% | 1.79% | 5.5分 |
| 26 | 科兴制药 | -2.40% | -2.70% | 5.3分 |
| 28 | 沃森生物 | -2.82% | 0.71% | 5.3分 |
| 30 | 派林生物 | -2.91% | 0.72% | 5.5分 |
| 32 | 赛升药业 | -3.21% | 3.91% | 4.9分 |
| 34 | 万泽股份 | -3.51% | -11.18% | 5.5分 |
| 36 | 长春高新 | -3.80% | 1.66% | 5.6分 |
| 38 | 博晖创新 | -4.25% | 1.71% | 5.0分 |
| 40 | 赛伦生物 | -4.93% | -1.31% | 4.7分 |
| 42 | - | -5.36% | -4.89% | 分 |
| 44 | - | -6.85% | -1.93% | 分 |
| 46 | 三生国健 | -7.71% | -1.75% | 5.3分 |
| 48 | 华兰疫苗 | -11.13% | 1.42% | 4.9分 |
| 50 | 康华生物 | -12.02% | -2.63% | 4.6分 |
| 52 | 荣昌生物 | -15.26% | -3.87% | 5.1分 |
| 54 | - | -28.95% | -1.25% | 分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：较强，高于行业平均，两项指标的行业排名分别为 23/72 ， 41/72。
[{"date":"2025-09-30","value":"4.48","vol":"-9.78"},{"date":"2025-06-30","value":"2.98","vol":"-0.61"},{"date":"2025-03-31","value":"1.12","vol":"0.46"},{"date":"2024-12-31","value":"9.71","vol":"-0.68"},{"date":"2024-09-30","value":"7.11","vol":"1.34"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
4.48 | 2.98 | 1.12 | 9.71 | 7.11 |
| 行业(%) | -9.78 | -0.61 | 0.46 | -0.68 | 1.34 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"46.32","vol":"67.61"},{"date":"2025-06-30","value":"47.63","vol":"68.28"},{"date":"2025-03-31","value":"48.06","vol":"68.43"},{"date":"2024-12-31","value":"49.13","vol":"69.85"},{"date":"2024-09-30","value":"50.52","vol":"70.47"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
46.32 | 47.63 | 48.06 | 49.13 | 50.52 |
| 行业(%) | 67.61 | 68.28 | 68.43 | 69.85 | 70.47 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 43/72 ， 37/72。
[{"date":"2025-09-30","value":"-14.40","vol":"45.25"},{"date":"2025-06-30","value":"-13.18","vol":"6902.04"},{"date":"2025-03-31","value":"-14.00","vol":"6125.27"},{"date":"2024-12-31","value":"14.00","vol":"47.35"},{"date":"2024-09-30","value":"37.49","vol":"175.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-14.40 | -13.18 | -14.00 | 14.00 | 37.49 |
| 行业(%) | 45.25 | 6902.04 | 6125.27 | 47.35 | 175.00 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-34.19","vol":"44.80"},{"date":"2025-06-30","value":"-27.89","vol":"5.44"},{"date":"2025-03-31","value":"-26.95","vol":"-8.46"},{"date":"2024-12-31","value":"21.76","vol":"-9.81"},{"date":"2024-09-30","value":"66.38","vol":"-52.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-34.19 | -27.89 | -26.95 | 21.76 | 66.38 |
| 行业(%) | 44.80 | 5.44 | -8.46 | -9.81 | -52.40 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，两项指标的行业排名分别为 28/72 ， 33/72。
[{"date":"2025-09-30","value":"0.17","vol":"0.22"},{"date":"2025-06-30","value":"0.11","vol":"0.14"},{"date":"2025-03-31","value":"0.04","vol":"0.06"},{"date":"2024-12-31","value":"0.30","vol":"0.29"},{"date":"2024-09-30","value":"0.21","vol":"0.22"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.17 | 0.11 | 0.04 | 0.30 | 0.21 |
| 行业(次) | 0.22 | 0.14 | 0.06 | 0.29 | 0.22 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.59","vol":"0.92"},{"date":"2025-06-30","value":"0.36","vol":"0.56"},{"date":"2025-03-31","value":"0.15","vol":"0.26"},{"date":"2024-12-31","value":"1.26","vol":"1.17"},{"date":"2024-09-30","value":"0.91","vol":"0.86"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.59 | 0.36 | 0.15 | 1.26 | 0.91 |
| 行业(次) | 0.92 | 0.56 | 0.26 | 1.17 | 0.86 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"15.23","vol":"1.84"},{"date":"2025-06-30","value":"-12.56","vol":"-1377.61"},{"date":"2025-03-31","value":"-30.92","vol":"-46.99"},{"date":"2024-12-31","value":"12.33","vol":"-11.33"},{"date":"2024-09-30","value":"15.21","vol":"-30.88"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 15.23 | -12.56 | -30.92 | 12.33 | 15.21 |
| 行业 | 1.84 | -1377.61 | -46.99 | -11.33 | -30.88 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"2.50","vol":"1.59"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"3.83","vol":"2.01"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 2.50 | - | 3.83 | - |
| 行业 | 0.00 | 1.59 | 0.00 | 2.01 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 14/72 ， 16/72。
[{"date":"2025-09-30","value":"2.93","vol":"6.00"},{"date":"2025-06-30","value":"3.67","vol":"6.64"},{"date":"2025-03-31","value":"4.19","vol":"7.75"},{"date":"2024-12-31","value":"3.74","vol":"6.72"},{"date":"2024-09-30","value":"4.06","vol":"7.02"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.93 | 3.67 | 4.19 | 3.74 | 4.06 |
| 行业 | 6.00 | 6.64 | 7.75 | 6.72 | 7.02 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.56","vol":"4.84"},{"date":"2025-06-30","value":"1.87","vol":"5.30"},{"date":"2025-03-31","value":"2.37","vol":"6.35"},{"date":"2024-12-31","value":"2.42","vol":"5.40"},{"date":"2024-09-30","value":"2.70","vol":"5.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.56 | 1.87 | 2.37 | 2.42 | 2.70 |
| 行业 | 4.84 | 5.30 | 6.35 | 5.40 | 5.66 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 32/72 ， 32/72。
[{"date":"2025-09-30","value":"16.25","vol":"28.18"},{"date":"2025-06-30","value":"13.04","vol":"26.73"},{"date":"2025-03-31","value":"12.94","vol":"26.03"},{"date":"2024-12-31","value":"14.37","vol":"25.81"},{"date":"2024-09-30","value":"13.57","vol":"24.44"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
16.25 | 13.04 | 12.94 | 14.37 | 13.57 |
| 行业(%) | 28.18 | 26.73 | 26.03 | 25.81 | 24.44 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.19","vol":"0.58"},{"date":"2025-06-30","value":"0.15","vol":"1.11"},{"date":"2025-03-31","value":"0.15","vol":"0.78"},{"date":"2024-12-31","value":"0.17","vol":"0.87"},{"date":"2024-09-30","value":"0.16","vol":"0.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.19 | 0.15 | 0.15 | 0.17 | 0.16 |
| 行业(%) | 0.58 | 1.11 | 0.78 | 0.87 | 0.40 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"3.91","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"5.87","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"6.12","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"7.45","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"8.09","blueLineValue":"0.85","type":"YC"}]